Rare Disease Day
February 28, 2022 - Imaging Endpoints guides biopharma companies in protocol development and manages the… Read More
April 2014 – Ron Korn, MD, PhD, of Imaging Endpoints will be a featured presenter at Pharmatech’s Biomarker Panel entitled “Development of Oncology Clinical Trials in the time of Precision, Personalized Medicine” occurring on May 15, 2014 at the Marriott San Francisco Waterfront. This event is a roundtable discussion with industry colleagues on the changing dynamics of the clinical trials industry and what techniques are needed in order to evolve with the oncoming advancements. Dr. Korn will be moderating the topic “Imaging Beyond RECIST: Imaging as a Surrogate Maker.”
To read the full press release, click here.